Cytochem Healthcare (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.50 M
as on 13-12-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -13.63%
(FY 2020)
- Profit -7603.63%
(FY 2020)
- Ebitda -153.92%
(FY 2020)
- Net Worth -327.30%
(FY 2020)
- Total Assets -36.19%
(FY 2020)
About Cytochem Healthcare (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Syed Mehdi, Urooj Mehdi, Syed Mahdi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232UP2006PTC032302
- Company No.
032302
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cytochem Healthcare (India)?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syed Mehdi  | Director | 29-Aug-2006 | Current |
| Urooj Mehdi | Director | 29-Aug-2006 | Current |
| Syed Mahdi | Additional Director | 30-Mar-2016 | Current |
| Shabistan Mahdi | Additional Director | 30-Mar-2016 | Current |
Financial Performance of Cytochem Healthcare (India).
Cytochem Healthcare (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 13.63% decrease. The company also saw a substantial fall in profitability, with a 7603.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 327.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cytochem Healthcare (India)?
In 2017, Cytochem Healthcare (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cytochem Healthcare (India)?
Cytochem Healthcare (India) has a workforce of 12 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cytochem Healthcare (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytochem Healthcare (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
